Residual perfusion defects in patients with pulmonary embolism are related to impaired fibrinolytic capacity.

Lami, Donatella; Cellai, Anna Paola; Antonucci, Emilia; Fiorillo, Claudia; Becatti, Matteo; Grifoni, Elisa; Cenci, Caterina; Marcucci, Rossella; Mannini, Lucia; Miniati, Massimo; Abbate, Rosanna; Prisco, Domenico

Lami, Donatella; Cellai, Anna Paola; Antonucci, Emilia; Fiorillo, Claudia; Becatti, Matteo; Grifoni, Elisa; Cenci, Caterina; Marcucci, Rossella; Mannini, Lucia; Miniati, Massimo; Abbate, Rosanna; Prisco, Domenico.

Afiliação

Lami D; Department of Experimental and Clinical Medicine, University of Florence, Florence Italy. Electronic address: dona.lami@tin.it.
Cellai AP; Department of Heart and Vessels, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Antonucci E; Department of Experimental and Clinical Medicine, University of Florence, Florence Italy.
Fiorillo C; Department of Biochemical Sciences, University of Florence, Florence, Italy.
Becatti M; Department of Biochemical Sciences, University of Florence, Florence, Italy.
Grifoni E; Department of Experimental and Clinical Medicine, University of Florence, Florence Italy.
Cenci C; Department of Experimental and Clinical Medicine, University of Florence, Florence Italy.
Marcucci R; Department of Experimental and Clinical Medicine, University of Florence, Florence Italy.
Mannini L; Department of Heart and Vessels, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Miniati M; Department of Experimental and Clinical Medicine, University of Florence, Florence Italy.
Abbate R; Department of Experimental and Clinical Medicine, University of Florence, Florence Italy.
Prisco D; Department of Experimental and Clinical Medicine, University of Florence, Florence Italy.

Thromb Res ; 134(3): 737-41, 2014 Sep.

Article em En | MEDLINE | ID: mdl-25074740

Assuntos

Fibrinólise; Circulação Pulmonar; Embolia Pulmonar/sangue; Embolia Pulmonar/fisiopatologia; Adulto; Idoso; Anticoagulantes/uso terapêutico; Biomarcadores/sangue; Testes de Coagulação Sanguínea; Feminino; Fibrinólise/efeitos dos fármacos; Humanos; Modelos Lineares; Modelos Logísticos; Masculino; Pessoa de Meia-Idade; Análise Multivariada; Razão de Chances; Imagem de Perfusão; Inibidor 1 de Ativador de Plasminogênio/sangue; Valor Preditivo dos Testes; Embolia Pulmonar/diagnóstico; Embolia Pulmonar/tratamento farmacológico; Recuperação de Função Fisiológica; Fatores de Tempo; Resultado do Tratamento

Palavras-chave

Clot lysis time; Fibrinolysis; Pulmonary embolism; Residual perfusion defects

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Embolia Pulmonar / Circulação Pulmonar / Fibrinólise Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google